219 results
8-K
EX-10.1
NSPR
InspireMD Inc
2 Apr 24
Departure of Directors or Certain Officers
9:14am
or dental benefits) shall be paid by the Executive until the earliest to occur of (i) the Executive’s death or (ii) the first day of the seventh month … cash payment on the earlier to occur of the Executive’s death or the first day of the seventh month following the Executive’s termination of employment
8-K
EX-10.2
NSPR
InspireMD Inc
2 Apr 24
Departure of Directors or Certain Officers
9:14am
benefits) shall be paid by the Executive until the earliest to occur of (i) the Executive’s death or (ii) the first day of the seventh month following … on the earlier to occur of the Executive’s death or the first day of the seventh month following the Executive’s termination of employment, except
8-K
EX-99.1
NSPR
InspireMD Inc
26 Mar 24
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
7:56am
stenting (CAS). The primary endpoint includes the composite of the following: incidence of the following major adverse events: death (all- cause … of the two-sided 95% confidence interval calculated from the observed primary endpoint rate is <11.6% and the p-value is <0.025.
1 Death (all
8-K
EX-99.1
NSPR
InspireMD Inc
6 Mar 24
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:07am
stenosis and at high risk for carotid endarterectomy (CEA) had an overall major adverse event rate (death, stroke or myocardial infarction, or DSMI) of 0.95
S-8
EX-99.3
6fpqo
2 Jan 24
Registration of securities for employees
5:16pm
8-K
EX-99.1
enioxk3d s6gaxi452sm
6 Nov 23
InspireMD Reports Third Quarter 2023 Financial Results and Provides
7:07am
8-K
g9zu88wwroicz9
1 Nov 23
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS
2:31pm
8-K
EX-99.1
pdpyqui hz
1 Nov 23
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS
2:31pm
S-8
EX-99.3
i3xauz9y
6 Oct 23
Registration of securities for employees
11:25am
8-K
EX-99.1
2lqwv91w069h
31 Aug 23
InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at VIVA23
8:10am
8-K
EX-99.1
665gq2u4m22 8kq
26 Jun 23
InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical Trial
8:25am
424B3
werq8d 1y9
2 Jun 23
Prospectus supplement
4:15pm
S-8
EX-99.3
jchtsm k29
17 May 23
Registration of securities for employees
4:00pm